Developmental Alterations in Adult-Onset Neurodegenerative Disorders: Lessons from Polyglutamine Diseases

Chandrakanth Reddy Edamakanti; Puneet Opal

doi:10.1002/mds.28657

Developmental Alterations in Adult-Onset Neurodegenerative Disorders: Lessons from Polyglutamine Diseases

Chandrakanth Reddy Edamakanti^*, Puneet Opal^*

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1548-1552
Number of pages	5
Journal	Movement Disorders
Volume	36
Issue number	7
DOIs	https://doi.org/10.1002/mds.28657
State	Published - Jul 2021

Funding

Puneet Opal declares no conflicts of interest with this review. He currently receives funding from the Hannah's Hope Fund and the Muscular Dystrophy Association for projects involving giant axonal neuropathy. He is performing a research study with the pharmaceutical company Biohaven on SCAs. He receives royalties from Uptodate. Chandrakanth R. Edamakanti declares no conflicts of interest and no funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership, or expert testimony for the past 12 months. C.R.E. receives support from the National Ataxia Foundation through a young investigator grant in spinocerebellar ataxia (YISCA) and from Northwestern University Clinical and Translational Sciences (NUCATS) & Northwestern Memorial Foundation (NMF) through DIXON TRANSLATIONAL RESEARCH GRANTS INITIATIVE in new Investigator catagory. P.O. receives support from the National Institutes of Health (1R01NS062051, 1R01NS082351, and R56NS108639).

ASJC Scopus subject areas

Clinical Neurology
Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/mds.28657

Cite this

@article{017233c50f724f2eaa46f867021da154,

title = "Developmental Alterations in Adult-Onset Neurodegenerative Disorders: Lessons from Polyglutamine Diseases",

author = "Edamakanti, {Chandrakanth Reddy} and Puneet Opal",

note = "Funding Information: Puneet Opal declares no conflicts of interest with this review. He currently receives funding from the Hannah's Hope Fund and the Muscular Dystrophy Association for projects involving giant axonal neuropathy. He is performing a research study with the pharmaceutical company Biohaven on SCAs. He receives royalties from Uptodate. Chandrakanth R. Edamakanti declares no conflicts of interest and no funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership, or expert testimony for the past 12 months. Funding Information: C.R.E. receives support from the National Ataxia Foundation through a young investigator grant in spinocerebellar ataxia (YISCA) and from Northwestern University Clinical and Translational Sciences (NUCATS) & Northwestern Memorial Foundation (NMF) through DIXON TRANSLATIONAL RESEARCH GRANTS INITIATIVE in new Investigator catagory. P.O. receives support from the National Institutes of Health (1R01NS062051, 1R01NS082351, and R56NS108639). ",

year = "2021",

month = jul,

doi = "10.1002/mds.28657",

language = "English (US)",

volume = "36",

pages = "1548--1552",

journal = "Movement Disorders",

issn = "0885-3185",

publisher = "John Wiley & Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Developmental Alterations in Adult-Onset Neurodegenerative Disorders

T2 - Lessons from Polyglutamine Diseases

AU - Edamakanti, Chandrakanth Reddy

AU - Opal, Puneet

N1 - Funding Information: Puneet Opal declares no conflicts of interest with this review. He currently receives funding from the Hannah's Hope Fund and the Muscular Dystrophy Association for projects involving giant axonal neuropathy. He is performing a research study with the pharmaceutical company Biohaven on SCAs. He receives royalties from Uptodate. Chandrakanth R. Edamakanti declares no conflicts of interest and no funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership, or expert testimony for the past 12 months. Funding Information: C.R.E. receives support from the National Ataxia Foundation through a young investigator grant in spinocerebellar ataxia (YISCA) and from Northwestern University Clinical and Translational Sciences (NUCATS) & Northwestern Memorial Foundation (NMF) through DIXON TRANSLATIONAL RESEARCH GRANTS INITIATIVE in new Investigator catagory. P.O. receives support from the National Institutes of Health (1R01NS062051, 1R01NS082351, and R56NS108639).

PY - 2021/7

Y1 - 2021/7

UR - http://www.scopus.com/inward/record.url?scp=85106050114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85106050114&partnerID=8YFLogxK

U2 - 10.1002/mds.28657

DO - 10.1002/mds.28657

M3 - Comment/debate

C2 - 34014004

AN - SCOPUS:85106050114

SN - 0885-3185

VL - 36

SP - 1548

EP - 1552

JO - Movement Disorders

JF - Movement Disorders

IS - 7

ER -

Developmental Alterations in Adult-Onset Neurodegenerative Disorders: Lessons from Polyglutamine Diseases

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this